Revised Pediatric Treatment Guidelines

From U.S. Food and Drug Administration

August 7, 2008

A note from TheBody.com: The field of medicine is constantly evolving. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

The Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection have been revised. The new version includes updated information on:

Recommended antiretroviral regimens for initial therapy
Nelfinavir, which now meets FDA limits for ethyl methane sulfonate (EMS)

The changes in this revision are highlighted in yellow throughout the text and tables.

The updated guidelines are available for download from the Pediatric Guidelines section of the AIDSinfo Web site. You can also request to receive them by mail or email from the AIDSinfo Order Publications section.

U.S. Updates Clinical Guidelines for Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children

Revised U.S. Adult and Adolescent Antiretroviral Treatment Guidelines; Also Revised Pediatric Guidelines

This article was provided by U.S. Food and Drug Administration. Visit the FDA's website to find out more about their activities and publications.

Read the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (PDF)

More on Pediatric HIV/AIDS Treatment Guidelines

Read the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (PDF)

More on Pediatric HIV/AIDS Treatment Guidelines

"You don't have to fight this fight by yourself." Watch Susan's Story >

HIV 'Undetectable = Untransmittable' Is a Game-Changing Fact. Why Isn't the Message More Public?

Celebrate U=U! What Undetectable = Untransmittable Means for the HIV Community

How the 12 Steps Have Helped Me Cope With HIV for Over 30 Years

What's New or Notable in HIV Treatment and Prevention Adherence?

Long-Acting Injectable HIV Treatment Moves Closer to Reality

More >>

TheBody.com App

Get Our Newsletters

My Health Tracker

Medication and Health Reminders

Assess Your Risk for HIV

The Body is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.